IMM H014
Alternative Names: IMM-H014; WS-117Latest Information Update: 01 Feb 2024
At a glance
- Originator Institute of Materia Medica
- Class Benzodioxoles; Biphenyl compounds; Esters; Hepatoprotectants; Morpholines; Small molecules
- Mechanism of Action NF-E2 related factor 1 stimulants; NF-E2-related factor 2 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Non-alcoholic steatohepatitis
Most Recent Events
- 06 Dec 2023 Phase-I clinical trials in Non-alcoholic steatohepatitis (In volunteers) in China (PO) (NCT06216041)
- 06 Dec 2023 Preclinical development for Non-alcoholic steatohepatitis in China (PO), prior to December 2023
- 02 Nov 2023 Institute of Materia Medica and Changchun Zhuanzhi Pharmaceutical has patents pending for IMM H014 worldwide